Healthcare regulatory insight
Prescription-medicine advertising: proposed restrictions extend the compliance discussion across distribution
The Ministry’s draft-policy announcement brings retail, wholesale and distribution licence holders into the proposed prior-sanction framework for Schedule H, H1 and X advertising. Businesses should review communication controls without treating the draft as enacted law.
Industry, model and participation details
Healthcare, Pharma & Life SciencesDigital, Telecom & ElectronicsManufacturing, MSME & Industrial PolicyMinistry of Health and Family Welfare · Institution named in the cited developmentDraft amendment · consultation linked to public Gazette availability
Read the insight →